Schaeffer's Top Stock Picks for '25

2 Pharma Stocks to Watch: Pfizer, Teva Pharmaceutical

TEVA is surging after the company's upbeat mid-stage trial results

Digital Content Manager
Dec 17, 2024 at 10:24 AM
facebook X logo linkedin


Pharma stocks Pfizer Inc (NYSE:PFE) and Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are in the spotlight today. The former's 2025 profit outlook came in above expectations, and the latter's drug with Sanofi (SNY) met the main goal of a mid-stage trial of being an effective treatment for Crohn's disease and ulcerative colitis. 

PFE was last seen up 3.7% at $26.18, chipping away at its 12.9% year-to-date deficit. A floor at $25 contained the equity's most recent pullback, while above the 40-day moving average is getting tested today. 

TEVA is up a 20% at $19.80 at last glance, trading at its highest level since February 2019 and on track for its best single-day percentage gain day since July 2022. The shares are bouncing off support at the $16 region now boast an 89.2% year-to-date lead.

Both equities are attracting attention in the options pits today. For PFE, 38,000 calls have been traded so far, double the volume typically seen at this point. The most active contract is the December 12.50 call. For TEVA, overall options volume is already running at 19 times the intraday average volume, with the December 20 put leading the charge.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?